| Suspended | IDP-023 g-NK Cells Plus Ocrelizumab in Patients With Progressive Multiple Sclerosis NCT06677710 | Indapta Therapeutics, INC. | Phase 1 |
| Not Yet Recruiting | Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refra NCT07513181 | Athos Therapeutics Inc | Phase 2 |
| Recruiting | Deciphering the Genetic Architecture of Autoimmune Diseases NCT06948110 | National Human Genome Research Institute (NHGRI) | — |
| Recruiting | Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease NCT07507201 | The Children's Hospital of Zhejiang University School of Medicine | EARLY_Phase 1 |
| Not Yet Recruiting | Clonal Hematopoiesis of Immunological Significance NCT05969821 | Assistance Publique - Hôpitaux de Paris | — |
| Not Yet Recruiting | Cluster of Differentiation 19 (CD19)/B Cell Maturation Antigen (BCMA) Chimeric Antigen Receptor T-Cell (CAR-T) NCT07490951 | Shenzhen Genocury Biotech Co., Ltd. | N/A |
| Not Yet Recruiting | Exploratory Study on LNP-mRNA Drugs Targeting CD19/BCMA for the Treatment of Relapsed and Refractory Autoimmun NCT07388212 | West China Hospital | EARLY_Phase 1 |
| Recruiting | Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatm NCT07246096 | Changhai Hospital | EARLY_Phase 1 |
| Recruiting | Clinical Study of AFN50 Injection in the Autoimmune Diseases NCT07408336 | AlphaNa Bioscience Company Limited | EARLY_Phase 1 |
| Not Yet Recruiting | To Evaluate the Safety and Tolerability of STR-P004 for the Treatment of Immune-mediated Kidney Diseases NCT07363954 | Starna Therapeutics | N/A |
| Not Yet Recruiting | Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease NCT07455578 | Seismic Therapeutic AU Pty Ltd | Phase 1 |
| Not Yet Recruiting | Integrating Vaccination Into Hospital Care Pathways for Vulnerable Patients NCT07391046 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Not Yet Recruiting | Exploratory Study on the Treatment of Relapsed and Refractory Immune Related Diseases With WGb-0301 Injection NCT07349823 | West China Hospital | EARLY_Phase 1 |
| Not Yet Recruiting | Exploratory Study on mRNA Therapy Targeting CD19 for the Treatment of Refractory Autoimmune Diseases NCT07362758 | Xinqiao Hospital of Chongqing | EARLY_Phase 1 |
| Recruiting | Exploratory Clinical Study of Second-generation CD19/BCMA Chimeric Antigen Receptor NK Cell Injection in Treat NCT07283315 | The Children's Hospital of Zhejiang University School of Medicine | EARLY_Phase 1 |
| Recruiting | CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease NCT07305116 | The Children's Hospital of Zhejiang University School of Medicine | Phase 1 |
| Active Not Recruiting | A Trial of Academic Detailing to Promote Prescribing of Biosimilars NCT07221890 | Brigham and Women's Hospital | N/A |
| Enrolling By Invitation | Quantum-Synaptic Immunotherapy Mapping Using Low-Frequency Electromagnetic Resonance and Machine Learning-Base NCT07221565 | Truway Health, Inc. | Phase 1 / Phase 2 |
| Recruiting | Natural History of Type 1 Interferonopathies: Insights From a European Cohort NCT07040774 | Imagine Institute | — |
| Not Yet Recruiting | A Study of CAR-T Cells in Subjects With Autoimmune Diseases NCT07040917 | Chinese PLA General Hospital | EARLY_Phase 1 |
| Not Yet Recruiting | Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Autoimmune Diseases NCT07161193 | Hebei Senlang Biotechnology Inc., Ltd. | Phase 1 / Phase 2 |
| Recruiting | Exploratory Clinical Study on the Safety of STR-P004 NCT07143617 | Beijing GoBroad Hospital | N/A |
| Not Yet Recruiting | Inectolizumab With Steroid Optimization in Newly Treated NMOSD NCT07159893 | First Affiliated Hospital of Wenzhou Medical University | N/A |
| Recruiting | Anti CD19/BCMA CAR Gene Therapy for Autoimmune Diseases NCT07121777 | Anhui Provincial Hospital | N/A |
| Recruiting | GT719 Injection for Moderate to Severe Refractory Autoimmune Diseases NCT07122076 | Grit Biotechnology | EARLY_Phase 1 |
| Recruiting | CAR-T Cells Therapy for Patients With Autoimmune Diseases NCT07052565 | Anhui Provincial Hospital | N/A |
| Recruiting | Single-cell Immune Response to Controlled Gluten Ingestion in Pediatric Celiac Disease NCT07362654 | Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud | N/A |
| Not Yet Recruiting | CAR-T Therapy for Refractory Autoimmune Diseases NCT07059169 | LiangZou | N/A |
| Recruiting | A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 NCT06575426 | Otsuka Pharmaceutical Factory, Inc. | Phase 1 / Phase 2 |
| Recruiting | The Role of Cytokines and Regulatory T Lymphocytes in Migraine Pathophysiology. NCT06426316 | University Hospital, Clermont-Ferrand | N/A |
| Not Yet Recruiting | Effect of Transcutaneous Electrical Acupoint Stimulation on Dysmenorrhea Among Autoimmune Disease Women NCT06976151 | Cairo University | N/A |
| Enrolling By Invitation | Network to Understand Reproductive Rheumatology Registry NCT06940869 | Duke University | — |
| Recruiting | A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-relat NCT06626919 | Arcellx, Inc. | Phase 1 |
| Completed | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of RLYB116 in Healthy Participants NCT06797375 | Rallybio | Phase 1 |
| Not Yet Recruiting | An Observational Study of Patients With Autoimmune Disease NCT05842824 | Target PharmaSolutions, Inc. | — |
| Not Yet Recruiting | JY231(JY231) Injection for the Treatment of Refractory Autoimmune Diseases (ADs) NCT06887985 | He Huang | N/A |
| Recruiting | Biocollection of Rare Pediatric-onset of Autoimmune and Autoinflammatory Diseases NCT06435468 | Hospices Civils de Lyon | N/A |
| Recruiting | Use of Acthar Gel Single-Dose Pre-Filled SelfJectTM Injector in Patients With Moderate-Severe Keratitis and Au NCT06964269 | Toyos Clinic | Phase 4 |
| Not Yet Recruiting | Efficacy and Safety of Efgartigimod Sequential Therapy with Telitacicept in Generalized Myasthenia Gravis NCT06827587 | First Affiliated Hospital of Wenzhou Medical University | N/A |
| Recruiting | Anti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune Disease NCT06792799 | The Children's Hospital of Zhejiang University School of Medicine | EARLY_Phase 1 |
| Not Yet Recruiting | Prospective Observational Study Evaluating the Safety and Efficacy of Immunomodulatory Therapies in Refractory NCT06757426 | Groupe français d'étude des Maladies Inflammatoires de loeil | — |
| Not Yet Recruiting | A Study of CAR-T Cells in Subjects with Autoimmune Diseases NCT06762119 | Zhejiang University | EARLY_Phase 1 |
| Recruiting | A Study of mRNA Encoding CD19/CD3 T Cell Engager (ABO2203) in Patients With Refractory Autoimmune Diseases NCT06747156 | Ruijin Hospital | EARLY_Phase 1 |
| Recruiting | Testimonials and Navigation in Rheumatology NCT06469788 | University of Alabama at Birmingham | N/A |
| Recruiting | A Randomized, Double-blind, Placebo-controlled, Dose-escalation Phase 1 Clinical Tiral in Healthy Male Volunte NCT06736587 | Daewoong Pharmaceutical Co. LTD. | Phase 1 |
| Recruiting | Retrospective Epidemiological Study of Patients in the National Cohort of the French TMA Center NCT07205861 | Assistance Publique - Hôpitaux de Paris | — |
| Not Yet Recruiting | Telitacicept and Low-dose Steroids in Refractory Myasthenia Gravis NCT06723548 | First Affiliated Hospital of Wenzhou Medical University | Phase 4 |
| Recruiting | Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Autoimmune Diseases NCT06688799 | Beijing GoBroad Hospital | Phase 1 / Phase 2 |
| Recruiting | Research of Predictive Factors of in Vitro Fertilization (IVF) Outcome AI-IVF Study NCT06872294 | Fondazione IRCCS Policlinico San Matteo di Pavia | — |
| Completed | A Dose Escalating Study of HC002 in Healthy Adult Volunteers NCT06670274 | Holoclara Aus Pty Ltd | Phase 1 |
| Recruiting | CD19 CAR-T in the Treatment of Relapsed/Refractory Autoimmune Diseases NCT06680388 | Institute of Hematology & Blood Diseases Hospital, China | EARLY_Phase 1 |
| Not Yet Recruiting | A Study of CAR-T Cells Targeting Autoimmune Diseases NCT06661811 | Beijing Boren Hospital | N/A |
| Enrolling By Invitation | A Phase 1 Study of Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune Disease NCT06375993 | Adicet Therapeutics | Phase 1 |
| Not Yet Recruiting | Digital Diagnostics and Intervention Services for Parkinson's Disease NCT06534177 | University of Exeter | — |
| Recruiting | Support-t Online Training in Youth Living With Type 1 Diabetes Transitioning to Adult Care NCT05910840 | Anne-Sophie Brazeau | N/A |
| Recruiting | Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases NCT06548607 | Nanjing Bioheng Biotech Co., Ltd. | EARLY_Phase 1 |
| Suspended | Clinical Study on Targeted CD19CAR-T Therapy for Autoimmune Diseases NCT06549296 | Nanjing Bioheng Biotech Co., Ltd. | EARLY_Phase 1 |
| Not Yet Recruiting | JWCAR201 for the Treatment of Hematology Malignancy and Autoimmune Diseases NCT06567080 | RenJi Hospital | Phase 1 |
| Not Yet Recruiting | Cancer as a complicATion in reCipients of Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Di NCT06507800 | Assistance Publique - Hôpitaux de Paris | — |
| Not Yet Recruiting | Risk and Clinical Consequences of Low Count Monoclonal B-cell Lymphocytosis (LC MBL) NCT06416267 | University of Haifa | — |
| Recruiting | Biomarkers in Autoimmune Disease of Nervous System NCT06502015 | Tongji Hospital | — |
| Recruiting | The diabEAT Study: Insulin dElivery Technologies And eaTing Behaviours in People With Type 1 Diabetes NCT07348432 | McGill University | — |
| Recruiting | Efficacy and Safety of Prophylactic Treatment for Pneumocystis Jirovecii Pneumonia in Patients With Autoimmune NCT06499233 | Tongji Hospital | Phase 4 |
| Recruiting | Clinical Performance of the New Plasma Filter PX2 in TPE Treatments NCT06382675 | Fresenius Medical Care Deutschland GmbH | N/A |
| Completed | Vitamin and Unsaturated Fatty Acid Supplements in Healthy and Uveitis Human Subjects NCT06491979 | Tianjin Medical University | N/A |
| Recruiting | Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE) NCT06350110 | Essen Biotech | Phase 1 / Phase 2 |
| Recruiting | Study to Evaluate the Safety and Feasibility of Diamyd® in Individuals at Risk for Type 1 Diabetes NCT05683990 | Diamyd Medical AB | Phase 2 |
| Recruiting | An Exploratory Clinical Study of CD19 CAR NK Cell Injection for the Treatment of Relapsed/Refractory Autoimmun NCT06464679 | Changhai Hospital | Phase 1 |
| Recruiting | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-A NCT06342713 | BeiGene | Phase 1 |
| Withdrawn | A Study to Investigate the Safety and Pharmacological Effect of a Single Intravenous Infusion of Belantamab in NCT06413511 | GlaxoSmithKline | Phase 1 |
| Withdrawn | Diabetes Islet Preservation Immune Treatment NCT02586831 | Camillo Ricordi and Jay Skyler | Phase 1 / Phase 2 |
| Recruiting | Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune Diseases NCT06428188 | Essen Biotech | Phase 1 / Phase 2 |
| Recruiting | Analysis of TPE Treatments With multiFiltratePRO NCT06272084 | Fresenius Medical Care Deutschland GmbH | — |
| Recruiting | Autoimmune Disease Treatment With Mesenchymal Stem Cells (MSCs) and CAR-T Cells NCT06435897 | Shenzhen Geno-Immune Medical Institute | Phase 1 / Phase 2 |
| Recruiting | Implementation of Support in the Care of Adults Living With Type 1 Diabetes NCT06069583 | McGill University | N/A |
| Recruiting | CD19-BAFF CAR-T Cells Therapy for Patients With Autoimmune Diseases NCT06279923 | Zhejiang University | EARLY_Phase 1 |
| Recruiting | An Exploratory Clinical Study of SCAR02 Targeting BCMA and CD19 for the Treatment of Refractory Autoimmune Dis NCT06503224 | The First Affiliated Hospital of University of Science and Technology of China | N/A |
| Withdrawn | The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune NCT06291415 | Hutchmed | Phase 1 |
| Recruiting | A Clinical Study of CD19 CAR NK Cells for the Treatment of Relapsed/Refractory B-cell Related Autoimmune Disea NCT06318533 | YANRU WANG | EARLY_Phase 1 |
| Recruiting | Rheumatology Diet Study NCT06339957 | University of Central Florida | — |
| Completed | Complement C5 mAb in the Treatment of Anti-GBM Disease NCT06513338 | Peking University First Hospital | Phase 2 |
| Not Yet Recruiting | JY231(Internal Clinical Drug Code) Injection for the Treatment of Refractory Autoimmune Diseases NCT06243159 | Shanxi Bethune Hospital | EARLY_Phase 1 |
| Recruiting | Systemic Treatments for Alopecia Areata Registry NCT06283316 | Erasmus Medical Center | — |
| Completed | A SHR0302 BA Study on Healthy Subjects NCT06202612 | Jiangsu HengRui Medicine Co., Ltd. | Phase 1 |
| Unknown | F01 in the Treatment of Autoimmune Diseases NCT06208280 | RenJi Hospital | Phase 1 |
| Recruiting | SYSTEMS-LEVEL ANALYSES OF IMMUNE DYSREGULATION NCT06248957 | Karolinska Institutet | — |
| Completed | Gut Microbiota In Children With Autoimmune Liver Disease and Its Effect on Treatment Response NCT06183190 | Institute of Liver and Biliary Sciences, India | — |
| Completed | First-in-Human Trial in Healthy Adult Volunteers to Evaluate Safety, Tolerability and PK of LAPIX Study Drug; NCT05853835 | LAPIX Therapeutics Inc. | Phase 1 |
| Active Not Recruiting | Group Education Trial to Improve Transition for Parents of Adolescents With T1D NCT05445284 | McGill University Health Centre/Research Institute of the McGill University Health Centre | N/A |
| Completed | In Vitro Effect Study of Interleukin-2 Muteins on Regulatory T Cells of Patients With Different Autoimmune, Al NCT05544448 | Assistance Publique - Hôpitaux de Paris | N/A |
| Completed | Epidural Stimulation in Multiple Sclerosis NCT06019611 | Kristin Zhao, PhD | N/A |
| Unknown | Treatment Strategies in IgG4-RD Patients With Re-elevation of Serum IgG4 Level During Maintenance Remission Pe NCT05974683 | Peking Union Medical College Hospital | N/A |
| Unknown | Intervention, Prognosis and Mechanism of Covid-19 Infection in Patients With Underlying Diseases NCT05965843 | The Second Affiliated Hospital of Chongqing Medical University | — |
| Recruiting | The Distribution of Immunoglobulin Isotype in Polyclonal Hypergammaglobulinemia in Systemic and Autoimmune Dis NCT06054373 | Centre Hospitalier Universitaire, Amiens | — |
| Recruiting | Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research NCT04806620 | Brain Inflammation Collaborative | — |
| Unknown | Role of LILRA3 in Ankylosing Spondylitis and Axial Psoriatic Patients NCT05915676 | Assiut University | — |
| Recruiting | IMPACT - AndHealth Autoimmune Research Registry NCT05883371 | AndHealth | — |
| Completed | A Post-marketing Observational Database Study Monitoring the Safety of CecolinⓇ NCT06824896 | Xiamen Innovax Biotech Co., Ltd | — |
| Recruiting | MUSic Therapy In Complex Specialist Neurorehabilitation NCT05777499 | University College, London | N/A |
| Enrolling By Invitation | AUD Biomarkers Study (Proteomic and Genomic Analysis of Biospecimens) NCT05889806 | Audubon Bioscience | — |
| Completed | Universal Capillary Screening for Chronic Autoimmune, Metabolic and Cardiovascular Diseases: Feasibility and A NCT05841719 | Emanuele Bosi | N/A |
| Completed | Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ATH-063 in Healthy Subjects NCT05807971 | Athos Therapeutics Inc | Phase 1 |
| Completed | Ukulele Playing to Improve Cognition in People with Multiple Sclerosis: a Feasibility Study NCT05792176 | University of Texas at Austin | N/A |
| Unknown | Efficacy and Safety of Android Artificial Pancreas System in Adult Patients With Type 1 Diabetes Mellitus in C NCT05726461 | Third Affiliated Hospital, Sun Yat-Sen University | N/A |
| Completed | Personalized Management of Autoimmune Diseases With AI-Guided (GenAIS TM) Dietary Supplementation NCT06470412 | S.LAB (SOLOWAYS) | N/A |
| Recruiting | An Open-Label, FIH Study Evaluating the Safety, Tolerability, and Efficacy of VCTX211 Combination Product in S NCT05565248 | CRISPR Therapeutics AG | Phase 1 / Phase 2 |
| Recruiting | A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune NCT06587828 | TScan Therapeutics, Inc. | — |
| Completed | Efficacy of Modification of Lifestyle in the Treatment of Ankylosing Spondylitis: a Pilot Study NCT05666115 | Camilo Jose Cela University | N/A |
| Recruiting | Biomarkers in Autoimmune Diseases, Vasculitis and Auto Inflammatory Diseases NCT05383339 | Assistance Publique - Hôpitaux de Paris | — |
| Completed | Transition to Adulthood Through Coaching and Empowerment in Rheumatology NCT05545839 | McMaster University | N/A |
| Completed | Efficacy and Safety of 308-nm Excimer Lamp Combined With Tacrolimus vs Tacrolimus as Monotherapy in Treating V NCT06035614 | Clarteis | N/A |
| Recruiting | Flemish Joint Effort for Biomarker PRofiling in Inflammatory Systemic Diseases NCT05670301 | University Hospital, Ghent | N/A |
| Terminated | A Study of Peresolimab (LY3462817) in Participants With Moderately-to-Severely Active Rheumatoid Arthritis NCT05516758 | Eli Lilly and Company | Phase 2 |
| Recruiting | Glycosylation Analysis of Lupus Anti-DNA Antibodies (GALA) NCT05394922 | University Hospital, Montpellier | — |
| Recruiting | CAR-T Cells Targeting Autoimmune Diseases NCT05459870 | Shenzhen Geno-Immune Medical Institute | Phase 1 / Phase 2 |
| Recruiting | Treatment Strategies for IgG4-RD Patients With Internal Organ Involvement NCT05789017 | Peking Union Medical College Hospital | N/A |
| Recruiting | Treatment Strategies for IgG4-RD Patients With Superficial Organ Involvement NCT05789030 | Peking Union Medical College Hospital | N/A |
| Unknown | Association of Silicone Breast Implants With Overall Wellbeingand Auto-immune Diseases NCT05400954 | The Netherlands Cancer Institute | — |
| Unknown | Sensitivity and Specificity of TSA-CBA for Autoantibodies Against Neural Antigen Determination NCT05414890 | Beijing Tiantan Hospital | — |
| Recruiting | Acceptability of Exoskeleton Assisted Walking for Persons With Mobility Issues Due to Multiple Sclerosis NCT04786821 | Sheffield Teaching Hospitals NHS Foundation Trust | N/A |
| Recruiting | Observational Study of Pediatric Rheumatic and Immunologic Diseases in China: The CAPRID Registry NCT06417502 | Peking Union Medical College Hospital | — |
| Completed | A Study to Evaluate the Safety, PK and PD of VIS171 in Participants (Healthy and With Autoimmune Disease) NCT05418101 | Otsuka Pharmaceutical Development & Commercialization, Inc. | Phase 1 |
| Unknown | Fetal-Hope Study: Home Monitoring of Fetal Heart Rate in SSA+ Pregnant Women NCT05958446 | ASST Fatebenefratelli Sacco | — |
| Unknown | Clinical Study of Targeting CD7 CAR-T Cells in the Treatment of Autoimmune Diseases NCT05239702 | Zhejiang University | EARLY_Phase 1 |
| Unknown | The Pathogenesis of Depression - Possible Autoimmune Mechanisms NCT05293899 | HaEmek Medical Center, Israel | — |
| Completed | An Open-Label, FIH Study Evaluating the Safety and Tolerability of VCTX210A Combination Product in Subjects Wi NCT05210530 | CRISPR Therapeutics AG | Phase 1 |
| Unknown | To Evaluate the Safety of Treating Rheumatologic and Metabolic Patients With Molecular Hydrogen Supplement. NCT05196295 | HoHo Biotech | Phase 1 |
| Unknown | Effectiveness of Bosentan Therapy in Patients With Systemic scleRosis and Progressive Digital ulcEr Disease. NCT05168215 | Elpen Pharmaceutical Co. Inc. | — |
| Unknown | Pyloric or Pseudopyloric Metaplasia of the Corpus Mucosa in Autoimmune Gastritis NCT05238181 | National Cheng-Kung University Hospital | — |
| Completed | Mass Evaluation of Lateral Flow Immunoassays for the Detection of SARS-CoV-2 (Covid-19) Antibodies NCT05148806 | Imperial College London | — |
| Completed | A Study of the Safety, Tolerability, Pharmacokinetics and Food Effect After Single and Multiple Ascending Oral NCT05218434 | Artax Biopharma Inc | Phase 1 |
| Unknown | A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Sjogren's Syndrome NCT05085431 | Zhejiang University | EARLY_Phase 1 |
| Unknown | A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Immune Nephritis NCT05085418 | Zhejiang University | EARLY_Phase 1 |
| Completed | The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic NCT05098600 | Faculty Hospital Kralovske Vinohrady | — |
| Unknown | A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Scleroderma NCT05085444 | Zhejiang University | EARLY_Phase 1 |
| Completed | One or Two Week Methotrexate Discontinuation on Efficacy of Influenza Vaccination in Rheumatoid Arthritis. NCT05069714 | Seoul National University Hospital | Phase 3 |
| Completed | Oral Vitamin D Supplementation Combined With Phototherapy as a Treatment for Vitiligo NCT04872257 | Hospital Universitario Dr. Jose E. Gonzalez | N/A |
| Unknown | A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Systemic Lupus Ery NCT05030779 | Zhejiang University | EARLY_Phase 1 |
| Recruiting | Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflamma NCT04902807 | Institut National de la Santé Et de la Recherche Médicale, France | — |
| Unknown | To Evaluate the Safety of Treating Autoimmune Diseases With Molecular Hydrogen Supplement NCT05116215 | HoHo Biotech | Phase 1 |
| Recruiting | X-linked Moesin Associated Immunodeficiency NCT06278337 | Institut National de la Santé Et de la Recherche Médicale, France | — |
| Unknown | Identification of Factors Associated With the Occurrence of Severe Forms of COVID-19 Infection in Patients Wit NCT05026892 | Assistance Publique - Hôpitaux de Paris | — |
| Unknown | Comparative Analysis of the Th17 Cellular Response in Active and Inactive Pemphigus Vulgaris Patients NCT04096222 | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | — |
| Unknown | Hypnosis in Internal Medecine NCT04698824 | University Hospital, Grenoble | — |
| Completed | A Study to Investigate the Effects of CBP-307 on the Heart Rate-corrected QT Interval (QTc) in Healthy Subject NCT04818229 | Connect Biopharma Australia Pty Ltd | Phase 1 |
| Completed | Anti-Argonaute Antibodies for the Diagnosis of Sensory Neuronopathies NCT05966350 | Centre Hospitalier Universitaire de Saint Etienne | — |
| Completed | Photo-Protection Trial (NB-UVB vs. Placebo) in High-risk Hospitalized COVID-19 Patients NCT04818970 | Cytokind, Inc. | N/A |
| Active Not Recruiting | Immuno-Oncology Database and Bioregistry NCT04656873 | UNC Lineberger Comprehensive Cancer Center | — |
| Recruiting | tDCS in Post-Acute COVID-19 Patients With SARDs NCT04890483 | University of Sao Paulo | N/A |
| Terminated | Immunological Response to COVID-19 Vaccine in Patients With Autoimmune and Inflammatory Diseases Treated With NCT04870411 | Assistance Publique - Hôpitaux de Paris | — |
| Recruiting | Study of STIM1 Membrane Expression NCT04978948 | University Hospital, Brest | — |
| Active Not Recruiting | Gluten Reduction and Risk of Celiac Disease NCT04593888 | Lund University | N/A |
| Recruiting | VNS Prospective Neuromodulation of Immune and Gastrointestinal Systems NCT03953768 | University of Louisville | N/A |
| Recruiting | Prospective Study of White Blood Cells NCT04838171 | Quell Therapeutics Limited | — |
| Unknown | Additional Autoimmune Diseases With Type 1 Diabetes in Pediatrics at Diabetes Diagnosis and During Follow-up NCT04789993 | Central Hospital, Nancy, France | — |
| Recruiting | Biologics And Clinical Immunology Cohort at Sinai NCT04784364 | Icahn School of Medicine at Mount Sinai | — |
| Completed | Humoral and T-Cell Responses to COVID-19 Vaccination in Multiple Sclerosis Patients Treated With Ocrelizumab T NCT04837651 | Dragonfly Research, LLC | — |
| Completed | Autologous Ex Vivo Expanded Regulatory T Cells in Ulcerative Colitis NCT04691232 | University of Erlangen-Nürnberg Medical School | Phase 1 |
| Completed | Effects of Low-Level Laser Therapy on Oxidative Stress Levels NCT04754607 | Istanbul Medipol University Hospital | N/A |
| Withdrawn | Distribution of Biospecimens From Biorepositories/Biobanks for Research Use NCT03884400 | iSpecimen Inc | — |
| Active Not Recruiting | A Study of the Safety and Activity of Sparsentan for the Treatment of Incident Patients With Immunoglobulin A NCT04663204 | University of Leicester | Phase 2 |
| Completed | Checkpoint Inhibitors in Patients With Cancer and Underlying Autoimmune Disease NCT04805099 | Hellenic Cooperative Oncology Group | — |
| Terminated | Trial of Naproxen Sodium for the Treatment of OCD in Children With PANDAS NCT04015596 | Massachusetts General Hospital | Phase 4 |
| Recruiting | Personalized Therapies in Inflammatory Complex Disease NCT03651518 | Assistance Publique - Hôpitaux de Paris | Phase 2 |
| Recruiting | Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the N NCT04561557 | Tongji Hospital | EARLY_Phase 1 |
| Recruiting | RT-CGM in Young Adults at Risk of DKA NCT04039763 | Imperial College London | N/A |
| Unknown | Efficacy of Individualized Rituximab in Maintaining Remission of Moderate and Severe Systemic Lupus Erythemato NCT04127747 | Second Affiliated Hospital, School of Medicine, Zhejiang University | Phase 4 |
| Completed | Safety and Tolerability of GX-P1 in Healthy Male Volunteers NCT04298749 | Genexine, Inc. | Phase 1 |
| Recruiting | Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions NCT04684602 | Thomas Advanced Medical LLC | Phase 1 / Phase 2 |
| Unknown | Withdraw Drug in Stable IgG4-Related Disease NCT04124861 | Peking Union Medical College Hospital | N/A |
| Enrolling By Invitation | Antibiotic Prophylaxis in High-Risk Arthroplasty Patients NCT04297592 | Mayo Clinic | Phase 4 |
| Unknown | Effectiveness and Safety of the Inactivated COVID-19 Vaccine in Thousands of Patients With Autoimmune Diseases NCT05831826 | Zhejiang Chinese Medical University | — |
| Unknown | Covid-19 in Patients With Chronic Inflammatory Rheumatism, Auto-immune or Auto-inflammatory Rare and Non-rare NCT04353609 | University Hospital, Lille | — |
| Recruiting | Montreal Immune-Related Adverse Events (MIRAE) Study NCT05139706 | Sir Mortimer B. Davis - Jewish General Hospital | — |
| Unknown | PK of Meropenem in Patients on Plasma Exchange NCT05042271 | Prince of Songkla University | — |
| Unknown | "Circulating Fetal DNA, Pregnancy And Immune Diseases" NCT04155086 | Assistance Publique - Hôpitaux de Paris | N/A |
| Terminated | Safety and Efficacy of Melatonin in Patients With Multiple Progressive Primary Sclerosis NCT03540485 | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | Phase 1 / Phase 2 |
| Recruiting | Exploring Immunological Markers Associated With Mental Fatigue in Graves' Disease NCT05678374 | Vastra Gotaland Region | — |
| Completed | Documentation of the Safety and Effectiveness Profile of the IgG Immunoadsorber GLOBAFFIN® in Clinical Routine NCT04078698 | Fresenius Medical Care Deutschland GmbH | N/A |
| Not Yet Recruiting | Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions NCT03899298 | R3 Stem Cell | Phase 1 |
| Unknown | A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Health Subject NCT04041544 | SinoMab BioScience Ltd | Phase 1 |
| Unknown | EBMT ADWP Prospective Non-interventional Study: Post-AHSCT Management in SSC Patients (NISSC-2) NCT03444805 | European Society for Blood and Marrow Transplantation | — |
| Terminated | Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease NCT03656627 | Alliance Foundation Trials, LLC. | Phase 1 |
| Completed | Study of Infections in Patients With Autoimmune Diseases Treated With Rituximab NCT03778840 | University Hospital, Lille | — |
| Completed | Immunomodulatory Therapy in Women With Autoimmune Premature Ovarian Insufficiency NCT05586737 | Angelica Lindén Hirschberg | Phase 2 |
| Completed | Human Absorption, Distribution and Metabolism Study (hAME) [14C]-KD025 NCT03907540 | Kadmon Corporation, LLC | Phase 1 |
| Completed | Single and Multiple Dose Pharmacokinetics of BMS-986165 in a Randomized, Double-Blind, Placebo-Controlled Stud NCT03956953 | Bristol-Myers Squibb | Phase 1 |
| Recruiting | Neuropathological Changes of the Intestinal Wall in Patients With Bowel Evacuation Disorders NCT05016700 | Evangelisches Klinikum Köln Weyertal gGmbH | — |
| Unknown | Clinical Characteristics of Interstitial Pneumonia With Autoimmune Features (IPAF) - a Multicenter Prospective NCT03870828 | Medical University of Silesia | — |
| Unknown | Endometrial Markers in Autoimmune Diseases NCT03843034 | Odense University Hospital | — |
| Unknown | Characterization of the Phenotypic Markers of B Cell Lymphocytes in Rheumatoid Arthritis NCT03793270 | Assiut University | — |
| Completed | Longevity Diet and the Fasting-mimicking Diet NCT07065955 | Fondazione Valter Longo | — |
| Completed | Clinical and Immunological Long-term Follow-up of Patients With Pemphigus Included in the "RITUXIMAB 3" Trial NCT03790293 | University Hospital, Rouen | Phase 3 |
| Completed | Characteristics of Tuberculosis Infection in Rheumatic Disease NCT03736278 | National Taiwan University Hospital | — |
| Unknown | Chronic Inflammatory Disease, Lifestyle and Risk of Disease NCT03456206 | University of Southern Denmark | — |
| Completed | A Study to Investigate the Pharmacokinetics (PK) of Modified Release (MR) Prototype Coated Tablet Formulations NCT03649412 | GlaxoSmithKline | Phase 1 |
| Completed | Personalized Lifestyle Intervention for Improving Functional Health Outcomes Using N-of-1 Tent-Umbrella-Bucket NCT04005456 | Metagenics, Inc. | N/A |
| Unknown | A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD) NCT03644069 | ImmusanT, Inc. | Phase 2 |
| Completed | Upper Extremity Function in Multiple Sclerosis Patients With Advanced Disability Treated With Ocrevus NCT03562975 | University of South Florida | — |
| Completed | Phase I Study of GSK2982772 in Japanese Healthy Male Participants NCT03590613 | GlaxoSmithKline | Phase 1 |
| Withdrawn | A Study to Evaluate the Safety, Mode of Action and Clinical Efficacy of GSK3050002 in Subjects With Psoriatic NCT02671188 | GlaxoSmithKline | Phase 1 |
| Completed | Disease-Modifying Treatments for Myasthenia Gravis NCT03490539 | Duke University | — |
| Completed | Investigating Genetic Risk for Type 1 Diabetes NCT03503747 | University of Oxford | — |
| Completed | Drug-drug Interaction Between Belumosudil, Itraconazole, Rifampicin, Rabeprazole, and Omeprazole in Healthy Vo NCT03530995 | Kadmon Corporation, LLC | Phase 1 |
| Unknown | Diagnostic and Imaging Indicators of Immunocardiomyopathic Patients NCT03885375 | Peking Union Medical College Hospital | — |
| Completed | Evaluating Innovations in Transition From Pediatric to Adult Care - The Transition Navigator Trial NCT03342495 | University of Calgary | N/A |
| Completed | Lymphocyte Sub-populations and Auto Immune Diseases NCT03901664 | University Hospital, Brest | — |
| Completed | Immune CHeckpoint Inhibitors Monitoring of Adverse Drug ReAction NCT03492242 | Groupe Hospitalier Pitie-Salpetriere | — |
| Recruiting | Maternal Autoimmune Disease Research Alliance (MADRA) Registry NCT03276923 | Duke University | — |
| Completed | Personal Lifestyle Engine (PLX) - Personal Lifestyle Medicine Center (PLMC) NCT04007939 | Metagenics, Inc. | — |
| Completed | Diamyd Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 Diabetes NCT03345004 | Diamyd Medical AB | Phase 2 |
| Completed | A Study of the Efficacy and Safety of Rituximab in Participants With Systemic Sclerosis NCT04274257 | Tokyo University | Phase 2 / Phase 3 |
| Completed | A Safety and Pharmacokinetic (PK) Study of GSK2982772 in Healthy Subjects NCT03305419 | GlaxoSmithKline | Phase 1 |
| Completed | A Study to Compare the Pharmacokinetics (PK) of GSK2982772 Following Administration of Different Modified Rele NCT03266172 | GlaxoSmithKline | Phase 1 |
| Completed | Chronic Inflammatory Disease, Lifestyle and Treatment Response NCT03173144 | University of Southern Denmark | — |
| Withdrawn | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Proof of Mechanism of GSK2618960 in Prima NCT03239600 | GlaxoSmithKline | Phase 2 |
| Terminated | Fecal Microbial Transplantation in Relapsing Multiple Sclerosis Patients NCT03183869 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Phase 2 |
| Unknown | Genetic Variants in Egyptian Patients Receiving HCQ(Hydroxychloroquine) NCT03180190 | Assiut University | — |
| Completed | A Retrospective and Prospective Cohort Study of the 21-day Fasting-like Diet in Patients With Metabolic and Au NCT03193177 | Tsinghua University | — |
| Completed | Day and Night Closed-loop in Young People With Type 1 Diabetes NCT02925299 | Jaeb Center for Health Research | N/A |
| Active Not Recruiting | Cognitive Changes After Major Joint Replacement - Full Trial (Cognigram 2) NCT03147937 | Dr. Stephen Choi | — |
| Completed | Experimental Autologous Mesenchymal Stem Cell Therapy in Treatment of Chronic Autoimmune Urticaria NCT02824393 | Celal Bayar University | EARLY_Phase 1 |
| Completed | Effect of BMS-986165 on the Pharmacokinetics of Rosuvastatin NCT03044873 | Bristol-Myers Squibb | Phase 1 |
| Completed | Immune Checkpoint Inhibitors and Pre-existing Autoimmune Diseases NCT03140137 | University Hospital, Brest | — |
| Active Not Recruiting | Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypert NCT02682511 | Cumberland Pharmaceuticals | Phase 2 |
| Completed | Autologous Tolerogenic Dendritic Cells for Treatment of Patients With Rheumatoid Arthritis NCT03337165 | Russian Academy of Medical Sciences | Phase 1 |
| Terminated | Trial Assessing Safety and Efficacy of Gammanorm® in Autoimmune Diseases NCT03656640 | Octapharma | — |
| Completed | A PH I Pilot Imaging Study to Evaluate Molecular Imaging Methods in HVs and pSS Pts NCT02899377 | GlaxoSmithKline | N/A |
| Unknown | Collection and Distribution of Biospecimens for Novel Research NCT05080907 | iSpecimen Inc | — |
| Recruiting | Collection and Distribution of Biospecimens for Novel Research Uses NCT03848962 | iSpecimen Inc | — |
| Completed | Home Testing of Day and Night Closed Loop With Pump Suspend Feature NCT02523131 | University of Cambridge | N/A |
| Completed | Exercise Snacks and Glutamine to Improve Glucose Control in Adolescents With Type 1 Diabetes NCT03199638 | Nemours Children's Clinic | N/A |
| Withdrawn | Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered Into Patients Wit NCT01453764 | Ageless Regenerative Institute | N/A |
| Unknown | Safety and Efficacy Study of Regulatory T Cells in Treating Autoimmune Hepatitis NCT02704338 | Nanjing Medical University | Phase 1 / Phase 2 |
| Recruiting | Genotype-phenotype Characterization Study on Genetic Diseases With Immune and Neurological Dysfunctions NCT06235580 | Imagine Institute | — |
| Completed | the Influence of Remote Ischemic Preconditioning on Inflammation During Human Endotoxemia NCT02602977 | Radboud University Medical Center | EARLY_Phase 1 |
| Completed | Coronary Artery and Systemic Autoimmune Disease: Diagnostics and Treatment NCT02510092 | Semmelweis University Heart and Vascular Center | N/A |
| Unknown | Transcriptome Analysis of the Peripheral Blood in CIDP NCT02404298 | Assistance Publique - Hôpitaux de Paris | N/A |
| Completed | Single Ascending Doses Study of Anti- Interleukin-7 Receptor α Monoclonal Antibody (GSK2618960) in Healthy Vol NCT02293161 | GlaxoSmithKline | Phase 1 |
| Completed | Increasing Plasma Adrenaline Levels Through Breathing Techniques - an Explorative Study NCT02417155 | Radboud University Medical Center | N/A |
| Completed | Phase 1 Study Accessing the Safety and Tolerability of CBP-307 NCT02280434 | Connect Biopharm LLC | Phase 1 |
| Unknown | Doxycycline Treatment in Mild Thyroid-Associated Ophthalmopathy NCT02203682 | Sun Yat-sen University | Phase 2 |
| Withdrawn | Examining the Immunological Process of Autoimmune Patients NCT02123147 | University of Florida | — |
| Unknown | Off-Label Use of Ribavirin in Management of Mucocutaneous Extrahepatic Manifestations of HCV Infection NCT02261662 | Tanta University | N/A |
| Completed | Immunomodulatory Effects of Subcutaneous Progesterone in Patients Affected by Autoimmune Diseases NCT04665232 | San Carlo Public Hospital, Potenza, Italy | — |
| Completed | Automated Closed-loop in Children and Adolescents With Type 1 Diabetes NCT02129868 | University of Cambridge | N/A |
| Completed | Transplantation of Autologous Stem Cells for the Treatment of Type 1 Diabetes Mellitus NCT02644759 | Stem Cells Arabia | Phase 1 / Phase 2 |
| Completed | Closing the Loop in Children and Adolescents With Type 1 Diabetes in the Home Setting NCT01778348 | University of Cambridge | Phase 2 |
| Completed | Safety and Clinical Outcomes Study: SVF Deployment for Orthopedic, Neurologic, Urologic, and Cardio-pulmonary NCT01953523 | Elliot Lander | N/A |
| Completed | Pharmacokinetics Study of Gamma-aminobutyric Acid NCT01917760 | Huashan Hospital | — |
| Completed | Concentration/Meditation Limits Inflammation NCT01835457 | Radboud University Medical Center | N/A |
| Completed | Microvascular and Fibrosis Imaging Study NCT01758250 | Duke University | — |
| Completed | Safety Study of CDP7657 in Patients With Systemic Lupus Erythematosus NCT01764594 | UCB Pharma | Phase 1 |
| Completed | EBMT ADWP Prospective Non Interventional Study : AutoHSCT in SSc Patients NCT02516124 | European Society for Blood and Marrow Transplantation | — |
| Unknown | Investigation of Immune Disorders and Deficiencies NCT01981785 | O & O Alpan LLC | — |
| Completed | Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders NCT01758042 | Massachusetts General Hospital | N/A |
| Completed | Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy NCT01727973 | Sun Yat-sen University | Phase 1 / Phase 2 |
| Enrolling By Invitation | Comparative Autoantibody and Immunologic Cell Marker Study NCT02422875 | Emory University | — |
| Unknown | Efficacy and Safety of Levamisole Combined With Standard Prednisolone in Warm Antibody Autoimmune Hemolytic An NCT01579110 | Institute of Hematology & Blood Diseases Hospital, China | Phase 2 |
| Completed | Use of Cross-linked Donor Corneas as Carriers for the Boston Keratoprosthesis NCT01582880 | Joseph B. Ciolino, MD | Phase 1 / Phase 2 |
| Completed | An MRI-guided Treatment Strategy to Prevent Disease Progression in Patients With Rheumatoid Arthritis NCT01656278 | Professor of Rheumatology, MD, DMSci, Kim Horslev-Petersen | N/A |
| Completed | Involvement of Viral Infections in the Pathogenesis of Chronic Lymphocytic Thyroiditis NCT03114267 | Centre Hospitalier Universitaire, Amiens | — |
| Completed | Clinical Characteristics of Allergy, Autoimmune and Rheumatic Diseases: A Ten Year Retrospective Study NCT01611636 | Far Eastern Memorial Hospital | — |
| Completed | Is a Diet Necessary When Corticosteroid Treatment is Prescribed? NCT01420133 | Assistance Publique - Hôpitaux de Paris | N/A |
| Completed | Acquired Chronic Erosive Gingivitis: Clinical Relevance of Papillary Gingival Biopsy NCT04293718 | Assistance Publique - Hôpitaux de Paris | — |
| Recruiting | A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) NCT01351545 | Center for International Blood and Marrow Transplant Research | — |
| Completed | Hydroxychloroquine Treatment of Dry Eyes in Patients With Primary Sjögren's Syndrome NCT01601028 | Seoul National University Hospital | Phase 3 |
| Completed | A Single and Repeat Dose PK/PD Study to Characterise Biomarker Response in Healthy Subjects Treated With Azith NCT01416350 | GlaxoSmithKline | Phase 1 |
| Recruiting | Ovarian Tissue Cryopreservation for Fertility Preservation NCT05875155 | University of Pittsburgh | — |
| Completed | Evaluation of Therapeutic Plasma Exchange (TPE) Procedure Using the AMICUS Device NCT01210716 | Fenwal, Inc. | Phase 3 |
| Completed | Vitamin D and Fish Oil for Autoimmune Disease, Inflammation and Knee Pain NCT01351805 | Brigham and Women's Hospital | N/A |
| Completed | Safety Study of CDP7657 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE) NCT01093911 | UCB Pharma | Phase 1 |
| Completed | Autologous Mesenchymal Stem Cells From Adipose Tissue in Patients With Secondary Progressive Multiple Sclerosi NCT01056471 | Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud | Phase 1 / Phase 2 |
| Completed | Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimuma NCT01004432 | Janssen Biotech, Inc. | Phase 3 |
| Completed | Vaccination Against Influenza in Autoimmune Diseases NCT01065285 | Assistance Publique - Hôpitaux de Paris | Phase 4 |
| Completed | Phase 0 Microdose Study NCT00975936 | GlaxoSmithKline | Phase 1 |
| Unknown | Calcitriol in the Treatment of Immunoglobulin A Nephropathy NCT00862693 | Peking University First Hospital | Phase 4 |
| Withdrawn | Pilot Trial to Assess Effect of CNI Conversion of Efalizumab on T Reg Cells NCT00777400 | University of California, San Francisco | Phase 1 / Phase 2 |
| Completed | Study of the Influence of Plasma Exchange on the Pharmacokinetics of Rituximab NCT00820469 | University Hospital, Toulouse | Phase 4 |
| Completed | The Biodistribution of 1-L-(2 Deoxy-2,- 18 Fluoroarabinofuranosyl) Cytosine ([18F]L-FAC) in Healthy Subjects a NCT01180868 | Jonsson Comprehensive Cancer Center | — |
| Completed | Ashwagandha: Effects on Stress, Inflammation and Immune Cell Activation NCT00817752 | National University of Natural Medicine | Phase 1 |
| Completed | Phase III Study of a Topical Gel Formulation for Treatment and Prevention of Raynaud's Phenomenon NCT00419419 | MediQuest Therapeutics | Phase 3 |
| Completed | Study of Oral Bacteria in Patients With Dry Mouth NCT00048685 | National Institute of Dental and Craniofacial Research (NIDCR) | — |
| Completed | Treatment of Multiple Sclerosis With Copaxone and Albuterol NCT00039988 | National Institute of Allergy and Infectious Diseases (NIAID) | N/A |
| Completed | Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autol NCT00010335 | Fred Hutchinson Cancer Center | Phase 1 |
| Completed | Phase II Study of High-Dose Cyclophosphamide in Patients With Severe Autoimmune Hematologic Disease NCT00010387 | Johns Hopkins University | Phase 2 |
| Unknown | Autologous Hematopoietic Stem Cell Transplantation for Refractory Autoimmune Diseases NCT00742300 | Charite University, Berlin, Germany | Phase 1 / Phase 2 |
| Completed | Treatment of Childhood Onset Psychiatric Disorders With Intravenous Immunoglobulin (IVIg) NCT00001768 | National Institute of Mental Health (NIMH) | Phase 3 |
| Completed | Study of Silicone-Associated Connective Tissue Diseases NCT00001330 | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | — |
| Completed | Genetic and Immune Studies of Rheumatoid Arthritis and Related Conditions NCT00001291 | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | — |
| Completed | Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Disease NCT00035308 | La Jolla Pharmaceutical Company | Phase 3 |